Literature DB >> 12763599

Endogenous somatostatin receptors mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells.

Duck-Joo Rhie1, Jong-Ho Sung, U-Sin Ha, Hee Jung Kim, Do Sik Min, Sang June Hahn, Myung-Suk Kim, Yang-Hyeok Jo, Shin Hee Yoon.   

Abstract

Somatostatin receptors are members of the G-protein-coupled receptor superfamily and exert their principal effects by coupling to inhibitory G-proteins. We used fura-2-based digital calcium imaging and assayed for [3H]inositol phosphates (IPs) to study the effects of somatostatin on intracellular calcium signaling in neuroblastomaxglioma NG108-15 cells. Both somatostatin-14 and octreotide induced concentration-dependent increases in intracellular Ca(2+) concentration ([Ca(2+)](i)). Thirty-four percent of the cells responded to treatment with 100 nM somatostatin-14. Somatostatin-induced responses were not blocked by the removal of extracellular calcium; instead, they were abolished by pretreatment with 100 nM thapsigargin, an agent that depletes and prevents refilling of intracellular Ca(2+) stores. Pretreatment with the inositol 1,4,5-trisphosphate (IP(3)) receptor antagonist xestospongin C (10 microM) for 20 min inhibited markedly the somatostatin-induced response. Somatostatin (100 nM) increased [3H]IPs formation. U73122 (1 microM), an inhibitor of phospholipase C (PLC), completely blocked the somatostatin-induced [Ca(2+)](i) increases and the formation of [3H]IPs. Pretreatment with pertussis toxin (PTX, 200 ng/ml) for 24 h blocked the somatostatin-induced responses. Thus, we conclude that activation of endogenous somatostatin receptors in NG108-15 cells induces the release of calcium from IP(3)-sensitive intracellular stores through PTX-sensitive G-protein-coupled PLC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763599     DOI: 10.1016/s0006-8993(03)02596-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Octyl Gallate Inhibits ATP-induced Intracellular Calcium Increase in PC12 Cells by Inhibiting Multiple Pathways.

Authors:  Yujie Guo; Yi Jae Hong; Hyun-Jong Jang; Myung-Jun Kim; Duck-Joo Rhie; Yang-Hyeok Jo; Sang June Hahn; Shin Hee Yoon
Journal:  Korean J Physiol Pharmacol       Date:  2010-02-28       Impact factor: 2.016

2.  Effects of Apigenin on Glutamate-induced [Ca](i) Increases in Cultured Rat Hippocampal Neurons.

Authors:  Ji-Hwa Han; Ki Jung Kim; Hyun-Jong Jang; Ju Ho Jang; Myung-Jun Kim; Ki Wug Sung; Duck-Joo Rhie; Yang-Hyeok Jo; Sang June Hahn; Mun-Yong Lee; Shin Hee Yoon
Journal:  Korean J Physiol Pharmacol       Date:  2008-04-30       Impact factor: 2.016

3.  Inhibitory effect of somatostatin-14 on L-type voltage-gated calcium channels in cultured cone photoreceptors requires intracellular calcium.

Authors:  Kuihuan Jian; Rola Barhoumi; Michael L Ko; Gladys Y-P Ko
Journal:  J Neurophysiol       Date:  2009-07-15       Impact factor: 2.714

4.  Epigallocatechin-3-gallate increases intracellular [Ca2+] in U87 cells mainly by influx of extracellular Ca2+ and partly by release of intracellular stores.

Authors:  Hee Jung Kim; Keun Sang Yum; Jong-Ho Sung; Duck-Joo Rhie; Myung-Jun Kim; Do Sik Min; Sang June Hahn; Myung-Suk Kim; Yang-Hyeok Jo; Shin Hee Yoon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-28       Impact factor: 3.000

5.  Grape seed proanthocyanidin extract inhibits glutamate-induced cell death through inhibition of calcium signals and nitric oxide formation in cultured rat hippocampal neurons.

Authors:  Seo-Hee Ahn; Hee Jung Kim; Imju Jeong; Yi Jae Hong; Myung-Jun Kim; Duck-Joo Rhie; Yang-Hyeok Jo; Sang June Hahn; Shin Hee Yoon
Journal:  BMC Neurosci       Date:  2011-08-03       Impact factor: 3.288

6.  Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation.

Authors:  Hui-Yun Zhang; Wen-Qian Xu; Yuan-Yuan Zheng; Emmanuel Omari-Siaw; Yuan Zhu; Xia Cao; Shan-Shan Tong; Jiang-Nan Yu; Xi-Ming Xu
Journal:  Oncotarget       Date:  2016-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.